183 related articles for article (PubMed ID: 10443520)
1. Tacrolimus (FK506) as primary immunosuppressant after lung transplantation.
Kur F; Reichenspurner H; Meiser BM; Welz A; Fürst H; Müller C; Vogelmeier C; Schwaiblmaier M; Briegel J; Reichart B
Thorac Cardiovasc Surg; 1999 Jun; 47(3):174-8. PubMed ID: 10443520
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial of tacrolimus versus cyclosporine in lung transplantation.
Keenan RJ; Konishi H; Kawai A; Paradis IL; Nunley DR; Iacono AT; Hardesty RL; Weyant RJ; Griffith BP
Ann Thorac Surg; 1995 Sep; 60(3):580-4; discussion 584-5. PubMed ID: 7545889
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
Fan Y; Xiao YB; Weng YG
Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
Trompeter R; Filler G; Webb NJ; Watson AR; Milford DV; Tyden G; Grenda R; Janda J; Hughes D; Ehrich JH; Klare B; Zacchello G; Bjorn Brekke I; McGraw M; Perner F; Ghio L; Balzar E; Friman S; Gusmano R; Stolpe J
Pediatr Nephrol; 2002 Mar; 17(3):141-9. PubMed ID: 11956848
[TBL] [Abstract][Full Text] [Related]
6. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
[TBL] [Abstract][Full Text] [Related]
8. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.
Cholongitas E; Shusang V; Germani G; Tsochatzis E; Raimondo ML; Marelli L; Senzolo M; Davidson BR; Patch D; Rolles K; Burroughs AK
Clin Transplant; 2011; 25(4):614-24. PubMed ID: 20718824
[TBL] [Abstract][Full Text] [Related]
12. Conversion of cyclosporine A to tacrolimus following heart transplantation.
Mathieu P; Carrier M; White M; Pellerin M; Perrault LP; Pelletier G; Pelletier LC
Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737
[TBL] [Abstract][Full Text] [Related]
13. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S
Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
[TBL] [Abstract][Full Text] [Related]
14. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
[TBL] [Abstract][Full Text] [Related]
15. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
16. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Kobashigawa JA; Patel J; Furukawa H; Moriguchi JD; Yeatman L; Takemoto S; Marquez A; Shaw J; Oeser BT; Subherwal S; Wu GW; Kawano J; Laks H
J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
[TBL] [Abstract][Full Text] [Related]
17. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[TBL] [Abstract][Full Text] [Related]
18. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
[No Abstract] [Full Text] [Related]
19. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
[TBL] [Abstract][Full Text] [Related]
20. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.
Sarahrudi K; Carretta A; Wisser W; Senbaklavaci O; Ploner M; Neuhauser P; Dobrovits M; Miwai Marta G; Papp A; Klepetko W
Transpl Int; 2002 Jan; 15(1):24-8. PubMed ID: 11875609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
